Part III Statistical Characterization of Brain Structures via Mreps - PowerPoint PPT Presentation

About This Presentation
Title:

Part III Statistical Characterization of Brain Structures via Mreps

Description:

Good. Function/ Psycho- pathology. Poor. 15. 20. 30. 40. 50. 60. 70 ... Establishing correspondence is a key issue for building statistical shape models. ... – PowerPoint PPT presentation

Number of Views:57
Avg rating:3.0/5.0
Slides: 37
Provided by: csU65
Learn more at: http://www.cs.unc.edu
Category:

less

Transcript and Presenter's Notes

Title: Part III Statistical Characterization of Brain Structures via Mreps


1
Part IIIStatistical Characterization of Brain
Structures via M-reps
  • Guido Gerig
  • Departments of Computer Science and Psychiatry
  • UNC Chapel Hill

2
Morphometry of Anatomical Structures
  • UNC Chapel Hill
  • Morphometry of brain structures in
  • Schizophrenia
  • Twin Studies (MZ/DZ/DS)
  • Autism, Fragile-X
  • Alzheimers Desease
  • Depression
  • Epilepsy

3
Representative Clinical Study Neuropathology of
Schizophrenia
  • When does it develop ?
  • Fixed or Progressive ?
  • Neurodevelopmental or Neurodegenerative ?
  • Neurobiological Correlations ?
  • Clinical Correlations ?
  • Treatment Effects ?

Noninvasive neuroimaging studies using MRI/fMRI
to study morphology and function
4
Natural History of Schizophrenia
Good
Function/
Psycho- pathology
Chronic/Residual
Premorbid
Prodromal
Progressive
Poor
15
20
30
40
50
60
70
Gestation/ Birth
Age (Years)
5
Study Structural analysis of caudate nucleus in
Schizophrenia
  • Processing Steps
  • Automatic whole brain tissue classification (EM
    segm.)
  • User-operated masking of caudate on label image
    (intra-, interrater reliability gt 0.95)
  • Surface parametrization of caudate shapes ?
    SPHARM PDM
  • Alignment/Normalization Surface Correspondence
  • Medial mesh generation (m-rep model)

6
Modeling of Caudate Shape
PDM
M-rep
Surface Parametrization
7
Basal Ganglia
Netters Atlas of Human Anatomy
8
Caudate Shape Analysis
  • Clinical Groups
  • Healthy controls (N30)
  • Typical drug treatment (30)
  • Atypical drug treatment (30)
  • Clinical questions
  • Shape difference between groups?
  • Drug/patient interaction?
  • Location type of changes

Mean Shapes per Group
9
Caudate volume analysis
  • Significantly larger volumes of SZ versus
    controls
  • Trend but not significant difference between
    Typ/Atyp
  • Where and what is difference?

preliminary analysis, not controlled for age
10
Mean Shapes CNTL vs. SZ
left
right
Overlay of aligned (transl/rot) original shapes
green CNTL / purple mesh SZ
11
Mean Shapes CNTL vs. SZ
Overlay of size normalized shapes green CNTL
/ purple mesh SZ
shape should not reflect size change
12
Alignment, Correspondence?
  • Choice of alignment coordinate system?
  • Establishing correspondence is a key issue for
    building statistical shape models.
  • Various methods for definition of correspondence
    exist (landmarks, high dimensional warping, PDM
    w. MDL refinement, ).
  • Resulting eigenmodes of deformation depend on
    these definitions.
  • Scaling of objects prior to shape analysis?

13
Object Alignment / Surface Homology
MZ pair
DZ pair
Surface Correspondence
14
Object Alignment before Shape Analysis
1stelli TR, no scal
1stelli TR, vol scal
Procrustes TRS
side
top
top
side
15
Correspondence through parameter space rotation
Parameters rotated to first order ellipsoids
  • Normalization using first order ellipsoid
  • Rotation of parameter space to align major axis
  • Spatial alignment to major axes

16
Correspondence ctd.
  • Rhodri Davies and Chris Taylor
  • MDL criterion applied to shape population
  • Refinement of correspondence to yield minimal
    description
  • 83 left and right hippocampal surfaces
  • Initial correspondence via SPHARM normalization
  • IEEE TMI August 2002

17
Correspondence ctd.
Homologous points before (blue) and after MDL
refinement (red).
MSE of reconstructed vs. original shapes using n
Eigenmodes (leave one out). SPHARM vs. MDL
correspondence.
18
Shape Representation Method Medial
Representation M-rep
Implied Surface
Skeletal Mesh (sampled)
Local Width (Radius)
Implied shape represents original shape with 99
volume overlap and ?0.05 MAD at boundary (M.
Styner, PhD thesis)
19
Shape Difference Analysis of M-rep
Mesh Position
Local Width
Mesh distance at corresponding nodes Object
deformation, Bending
Grp A
Radius difference at corresponding nodes Local
width change
A and B aligned, superimposed
Grp B
20
Statistical Analysis
  • Shapes represented by m-rep Significant feature
    reduction, multi-scale
  • Still Number of features ? sample size.
  • Variability hides shape changes.
  • Shapes not represented by scalar values Standard
    MANOVA analysis inappropriate.
  • Often PCA on features, selection of small of
    Eigenmodes, Fisher linear discriminant, leave one
    out test for classification.
  • But Fisher LD not robust, of features?, feature
    selection?, does PCA reflect group differences?

21
Statistical Analysis
22
Shape analysis using medial representations
radius
  • Local width (radius) differences Growth, Atrophy
    (Loss)
  • Positional differences Bending, Deformation

23
(No Transcript)
24
Permutation Test
  • Monte Carlo Sampling (mk30)
  • Mean differences from 1000 permutations
  • Test original difference 22.8 versus
    distribution p0.025

experiments
25
Results Caudate Shape AnalysisIntegrated local
effects
  • Typical group shows larger shape difference to
    controls than atypical group
  • Significant shape difference between typical and
    atypical treatment group
  • Shape distances not shown in combined SZ versus
    controls analysis
  • Treatment effect or clinical selection bias?
  • Experimental study design, result need to be
    verified in cross-validation study

Non-parametric permutation test
26
Results Caudate Shape AnalysisComparison of
Surfaces
  • Significant shape changes mostly in the head of
    the caudate
  • Shape effect on left side larger than on right
    side
  • Local significance tests in progress

CNTL Atyp Typ
27
Shape Difference Where and What?Local Mesh
Deformation
  • Atypical versus Typical drug treatment groups (N
    30)
  • Local Deformation (Euclidean dist. between
    corresponding nodes)
  • Local significance tests (nonparametric
    permutation tests)

mesh with node differences plt0.01
p-values per mesh node
mesh with nodes plt0.05
28
Shape Difference Where and What?Local Mesh
Deformation
  • Atypical versus Typical drug treatment groups (N
    30)
  • Local Deformation (Euclidean dist. between
    corresponding nodes)

mesh with nodes plt0.05
29
Shape Difference Where and What?Local Width
Difference
  • Atypical versus Typical drug treatment groups
    (N_atypN_typ 30)
  • Local Width Diff. (Radius diff. between
    corresponding node positions)
  • Local significance tests (nonparametric
    permutation tests)

mesh with node differences plt0.05
p-values per mesh node
mesh with nodes plt0.05
30
Shape Difference Where and What?Local Width
Difference
  • Atypical versus Typical drug treatment groups
    (N_atypN_typ 30)
  • Local Width Diff. (Radius diff. between
    corresponding node positions)

mesh with nodes plt0.05
31
Shape Difference Where and What?Local Width
Difference
  • Atypical versus Typical drug treatment groups
    (N_atypN_typ 30)
  • Local Width Diff. (Radius diff. between
    corresponding node positions)

Morphing between Atypical (thinner) and Typical
(thicker)
32
Discussion Caudate Study
Width and mesh deformation mostly in caudate
body/head. Secondary mesh deformation
posteriorly Typical treatment group differs from
Controls, but not Atypical. Clinical
implications? Study caudate shape change
relative to neighboring shapes.
Netters Atlas of Human Anatomy
33
Study Hippocampal Shape in Schizophrenia
  • IRIS Tool for interactive image segmentation.
  • Manual contouring in all orthogonal sections.
  • 2D graphical overlay and 3D reconstruction.
  • Hippocampus segmentation protocol (following
    Duvernoy).
  • Hippocampus reliability gt0.95 intra-, gt0.85
    inter-rater)

34
Hippocampal Volume Analysis
  • Left smaller than right
  • SZ smaller than CNTRL, both left and right
  • Variability SZ larger than CNTL

35
3D Shape Variability Left Hippocampus of 90
Subjects
36
Hippocampal Shape Analysis
Left and right hippocampus Comparison of mean
shapes CNTL-SZ (signed distance magnitude
relative to SZ template)
Left
Right
Movie Flat tail SZ, curved tail CNTL
Movie Flat tail SZ, curved tail CNTL
37
Hippocampus M-rep Global Local Statistical
Analysis
Hippocampus Integrated difference to template
shape (structures size normalized)
individual m-rep
local group discrimination statistics
Width (plt0.75)
Deformation (plt0.0001)
SZ
SZ
CNTL
CNTL
plt0.01
G. Gerig M. Styner
38
Local Statistical Tests
Medial representation study confirms Hippocampal
tail is region with significant deformation.
39
Statistical Analysis of M-rep representations
Difference in hippocampus shape between SZ and
CNTRL as measured by M-rep deformation
  • Work in progress Keith Muller, Emily Kistner, M.
    Styner, J. Lieberman, G. Gerig, UNC Chapel Hill
  • Systematic embedding of interaction of age,
    duration of illness and drug type into local
    statistical analysis
  • Correction for multiple tests

Repeated measures ANOVA, cast as a General
Linear Multivariate Model, as in Muller, LaVange,
Ramey, and Ramey (1992, JASA). Exploratory
analysis included considering both the "UNIREP"
Geisser-Greenhouse test and the "MULTIREP" Wilks
test.
M-rep 3x8 mesh
Tail
Head
40
Model Row x Col x Drug (y/n) x Age p 0.0097
Patient-CNTL Deformation Difference at Age 40
Deformation at mesh nodes (mm)
Patient-CNTL Deformation Difference at Age 30
AGE
Patient-CNTL Deformation Difference at Age 20
Difference in hippocampus shape between patients
and controls Located mostly in the tail of the
hippocampus, becomes more pronounced over time.
Tail
Head
41
Comparison to CNTLs
Deformation at mesh nodes (mm)
Change in hippocampus shape over ten years for
controls
Tail
Head
42
Patients vs. Controls Local width L/R asymmetry
analysis
Model Row x Col x Drug type x Age Left/Right
width asymmetry p 0.0097
Radius diff. at mesh nodes log (mm)
40
40
30
30
AGE
20
20
Typical Drug
Atypical Drug
43
Preliminary conclusions local asymmetry of width
analysis
  • Reduction in control/patient difference in
    hippocampus width asymmetry seems more pronounced
    in the atypical group.
  • Differences between patients and controls in
    hippocampus width asymmetry decrease over time.
  • Given the expected atrophy over time due to
    aging, it seems that the hippocampus of a young
    schizophrenic looks like the hippocampus of an
    older control.
  • Atypical treated patients start (at an early age)
    less far from the normals than do those treated
    with typical drugs (TREATMENT EFFECT OR CLINICAL
    SELECTION BIAS?).

44
Conclusions
  • Shape represents changes not reflected by volume
    analysis
  • Several clinical studies Shape discriminates
    better than volume
  • M-rep superior to boundary models
  • separate analysis of local width/bending
  • results explained in natural language terms
  • potential to analyze figure-subfigure
    relationships and figures in anatomic context
  • Improved statistical framework for discrimination
    in development

45
Acknowledgements
  • Martin Styner
  • Sean Ho
  • Sampath Vetsa
  • Keith Muller
  • Jeffrey A. Lieberman
  • Stephen M. Pizer and M-rep team
  • Talk at http//midag.cs.unc.edu
Write a Comment
User Comments (0)
About PowerShow.com